Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: GENZYME · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENENTECH via PODESTA GROUP, INC.
2007 · mid_year · MA
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Source: Senate LDA
| ORANGE COUNTY, FLORIDA |
| 4 |
| 2006–2007 |
| RELX INC. | 4 | 2006–2007 |
| GENZYME | 3 | 2006–2007 |
| CHIRON | 2 | 2005–2006 |
| PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA | 2 | 2005–2006 |
| SIGMA TAU PHARMACEUTICALS | 2 | 2006 |
| PFIZER, INC. | 1 | 2006 |
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: GENZYME · Firm: PODESTA GROUP, INC.
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 2606, 340 B Program Improvement and Integrity Act of 2007, 340B drug price expansion SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare and drug pricing provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare and drug pricing provisions S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation issues H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation issues S. 1644, Department of Homeland Security Appropriations Act, drug importation issues H. R. 2638, Department of Homeland Security Appropriations Act, drug importation issues H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: GENENTECH · Firm: PODESTA GROUP, INC.
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Possible DRA technical language H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions
Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012.
Client: GENZYME · Firm: PODESTA GROUP, INC.
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
* Follow-on biologics S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics FDA Drug Safety Oversight S. 1082, Prescription Drug User Fee Amendments, drug safety provisions H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Access to Life-Saving Medicine Act
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Enhancing Drug Safety and Innovation Act of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Enhancing Drug Safety and Innovation Act of 2007
Client: GENZYME · Firm: PODESTA GROUP, INC.
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Enhancing Drug Safety and Innovation Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Enhancing Drug Safety and Innovation Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Enhancing Drug Safety and Innovation Act of 2007
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
Intellectual property and process patent issues S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
Patent Reform Act of 2007
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent Reform Act of 2007, process patents H R. 1908, Patent Reform Act of 2007, process patents
S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: GENZYME · Firm: PODESTA GROUP, INC.
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: AMGEN · Firm: PODESTA GROUP, INC.
* Follow-on biologics S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics FDA Drug Safety Oversight S. 1082, Prescription Drug User Fee Amendments, drug safety provisions H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions
340B Program Improvement and Integrity Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
340B Program Improvement and Integrity Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
340B Program Improvement and Integrity Act of 2007
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Possible DRA technical language H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions
340B Program Improvement and Integrity Act of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 2606, 340 B Program Improvement and Integrity Act of 2007, 340B drug price expansion SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions
340B Program Improvement and Integrity Act of 2007
Client: GENZYME · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
Food and Drug Administration Amendments Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Food and Drug Administration Amendments Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Food and Drug Administration Amendments Act of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Food and Drug Administration Amendments Act of 2007
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
Food and Drug Administration Amendments Act of 2007
Client: AMGEN · Firm: PODESTA GROUP, INC.
* Follow-on biologics S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics FDA Drug Safety Oversight S. 1082, Prescription Drug User Fee Amendments, drug safety provisions H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions
Food and Drug Administration Amendments Act of 2007
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Food and Drug Administration Amendments Act of 2007
Client: GENZYME · Firm: PODESTA GROUP, INC.
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Social Security Number Privacy and Identity Theft Prevention Act of 2007
Client: RELX INC · Firm: PODESTA GROUP, INC.
H. R. 964, SPY Act, entire bill S. 495, Personal Data Privacy and Security Act of 2007, entire bill H. R. 958, Data Accountability and Trust Act, entire bill H. R. 3046, Social Security Number Privacy and Identity Theft Prevention Act of 2007, entire bill
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Possible DRA technical language H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions
Medicare Prescription Drug Price Negotiation Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
Medicare Prescription Drug Price Negotiation Act of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 2606, 340 B Program Improvement and Integrity Act of 2007, 340B drug price expansion SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions
Medicare Prescription Drug Price Negotiation Act of 2007
Client: GENZYME · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
Medicare Prescription Drug Price Negotiation Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
Veteran Claims Backlog Reduction Act of 2008
Client: ORANGE COUNTY, FLORIDA · Firm: PODESTA GROUP, INC.
3. HR 5576 - Transportation, Treasury, Housing and Urban Development, the Judiciary, the District of Columbia, and Independent Agencies Appropriations Act, 2006/HUD/EDI, DOT, FY07 4. HR 2641/S 1751 - FY08 - Energy & Water, DOE, Energy Supply & Conservation 5. HR 3043/S1710 - FY08 - LHHS, HRSA, SAMHSA 6. HR 3074/S 1789 - FY08 - Transportation-HUD, STP 7. HR 3093/S 1745 - FY08 - Commerce, Justice, Science, Byrne 1. HR 5672 - SSJ, Commerce, and Related Agencies Appropriation Act, FY2007/Byrne Grants Accts. 2. HR 5647 - Department of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006/SAMHSA, HRSA accounts, FY07
To provide public charter school options for those students that attend schools that are in need of improvement and have been identified for restructuring and those schools with a graduation rate of less than 60 percent, and for other purposes.
Client: ORANGE COUNTY, FLORIDA · Firm: PODESTA GROUP, INC.
3. HR 5576 - Transportation, Treasury, Housing and Urban Development, the Judiciary, the District of Columbia, and Independent Agencies Appropriations Act, 2006/HUD/EDI, DOT, FY07 4. HR 2641/S 1751 - FY08 - Energy & Water, DOE, Energy Supply & Conservation 5. HR 3043/S1710 - FY08 - LHHS, HRSA, SAMHSA 6. HR 3074/S 1789 - FY08 - Transportation-HUD, STP 7. HR 3093/S 1745 - FY08 - Commerce, Justice, Science, Byrne 1. HR 5672 - SSJ, Commerce, and Related Agencies Appropriation Act, FY2007/Byrne Grants Accts. 2. HR 5647 - Department of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006/SAMHSA, HRSA accounts, FY07
Women's Business Ownership Act of 2008
Client: ORANGE COUNTY, FLORIDA · Firm: PODESTA GROUP, INC.
3. HR 5576 - Transportation, Treasury, Housing and Urban Development, the Judiciary, the District of Columbia, and Independent Agencies Appropriations Act, 2006/HUD/EDI, DOT, FY07 4. HR 2641/S 1751 - FY08 - Energy & Water, DOE, Energy Supply & Conservation 5. HR 3043/S1710 - FY08 - LHHS, HRSA, SAMHSA 6. HR 3074/S 1789 - FY08 - Transportation-HUD, STP 7. HR 3093/S 1745 - FY08 - Commerce, Justice, Science, Byrne 1. HR 5672 - SSJ, Commerce, and Related Agencies Appropriation Act, FY2007/Byrne Grants Accts. 2. HR 5647 - Department of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006/SAMHSA, HRSA accounts, FY07
H. R. 964, SPY Act, entire bill S. 495, Personal Data Privacy and Security Act of 2007, entire bill H. R. 958, Data Accountability and Trust Act, entire bill H. R. 3046, Social Security Number Privacy and Identity Theft Prevention Act of 2007, entire bill
H. R. 964, SPY Act, entire bill S. 495, Personal Data Privacy and Security Act of 2007, entire bill H. R. 958, Data Accountability and Trust Act, entire bill H. R. 3046, Social Security Number Privacy and Identity Theft Prevention Act of 2007, entire bill
Safer Drug Assessment Technology Advancement Act
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Safer Drug Assessment Technology Advancement Act
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Safer Drug Assessment Technology Advancement Act
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Safer Drug Assessment Technology Advancement Act
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent Reform Act of 2007, process patents H R. 1908, Patent Reform Act of 2007, process patents
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
Intellectual property and process patent issues S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
Best Pharmaceuticals for Children Amendments of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Best Pharmaceuticals for Children Amendments of 2007
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Best Pharmaceuticals for Children Amendments of 2007
Client: GENZYME · Firm: PODESTA GROUP, INC.
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
340B Program Improvement and Integrity Act of 2007
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Possible DRA technical language H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions
340B Program Improvement and Integrity Act of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 2606, 340 B Program Improvement and Integrity Act of 2007, 340B drug price expansion SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions
340B Program Improvement and Integrity Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
340B Program Improvement and Integrity Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
340B Program Improvement and Integrity Act of 2007
Client: GENZYME · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Affordable Biologics for Consumers Act
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Department of Homeland Security Appropriations Act, 2008
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Department of Homeland Security Appropriations Act, 2008
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Department of Homeland Security Appropriations Act, 2008
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Department of Homeland Security Appropriations Act, 2008
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare and drug pricing provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare and drug pricing provisions S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation issues H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation issues S. 1644, Department of Homeland Security Appropriations Act, drug importation issues H. R. 2638, Department of Homeland Security Appropriations Act, drug importation issues H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Biologics Price Competition and Innovation Act of 2007
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
Biologics Price Competition and Innovation Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Biologics Price Competition and Innovation Act of 2007
Client: GENENTECH · Firm: PODESTA GROUP, INC.
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Biologics Price Competition and Innovation Act of 2007
Client: EMD SERONO INC · Firm: PODESTA GROUP, INC.
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
NOVO NORDISK INC via PODESTA GROUP, INC.
2007 · mid_year · MM
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding
S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, drug importation/FDA provisions H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Possible DRA technical language H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2007 · mid_year · MM
S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 2606, 340 B Program Improvement and Integrity Act of 2007, 340B drug price expansion SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare and drug pricing provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare and drug pricing provisions S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation issues H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation issues S. 1644, Department of Homeland Security Appropriations Act, drug importation issues H. R. 2638, Department of Homeland Security Appropriations Act, drug importation issues H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
NORVARTIS VACCINES & DIAGNOSTICS INC via PODESTA GROUP, INC.
2007 · mid_year · MM
2007 · mid_year · MM
* Follow-on biologics S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics FDA Drug Safety Oversight S. 1082, Prescription Drug User Fee Amendments, drug safety provisions H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions
Intellectual property and process patent issues S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
Medicare coverage and reimbursement of Erythropoiesis-Stimulating Agents
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
RELX INC via PODESTA GROUP, INC.
2007 · mid_year · MM
H. R. 964, SPY Act, entire bill S. 495, Personal Data Privacy and Security Act of 2007, entire bill H. R. 958, Data Accountability and Trust Act, entire bill H. R. 3046, Social Security Number Privacy and Identity Theft Prevention Act of 2007, entire bill
S. 1642, Higher Education Amendments of 2007, textbook pricing provisions S. 945, College Textbook Affordability Act of 2007, entire bill
Copyright issues
GENZYME via PODESTA GROUP, INC.
2007 · mid_year · MM
S. 1145, Patent Reform Act of 2007, process patents H R. 1908, Patent Reform Act of 2007, process patents
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2007 · mid_year · MM
H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
GENENTECH via PODESTA GROUP, INC.
2007 · mid_year · MM
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
ORANGE COUNTY, FLORIDA via PODESTA GROUP, INC.
2007 · mid_year · MM
* Central Florida Veteran's Hospital
3. HR 5576 - Transportation, Treasury, Housing and Urban Development, the Judiciary, the District of Columbia, and Independent Agencies Appropriations Act, 2006/HUD/EDI, DOT, FY07 4. HR 2641/S 1751 - FY08 - Energy & Water, DOE, Energy Supply & Conservation 5. HR 3043/S1710 - FY08 - LHHS, HRSA, SAMHSA 6. HR 3074/S 1789 - FY08 - Transportation-HUD, STP 7. HR 3093/S 1745 - FY08 - Commerce, Justice, Science, Byrne 1. HR 5672 - SSJ, Commerce, and Related Agencies Appropriation Act, FY2007/Byrne Grants Accts. 2. HR 5647 - Department of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006/SAMHSA, HRSA accounts, FY07
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
ORANGE COUNTY, FLORIDA via PODESTA GROUP, INC.
2006 · year_end · YA
HR 5576, Transportation, Treasury, Housing and Urban Development, the Judiciary, the District of Columbia, and Independent Agencies Appropriations Ace, 2006/HUD/EDI, DOT Work to acquire funding (appropriations). H.R. 5672, SSJ Commerce, and Related Agencies Appropriation Act, 2006/Byrne Grants Accts. H.R. 5647, Department of Labor, Health and Human Services, and Education and related Agencies Appropriations Act, 2006/SAMHSA, HRSA accounts
Central Florida Veteran's Hospital
* Orange County Bird Flu Summit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
RELX INC via PODESTA GROUP, INC.
2006 · mid_year · RA
EMD SERONO INC via PODESTA GROUP, INC.
2006 · year_end · YY
S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 471, Stem Cell Research Enhancement Act of 2005. Biologics, generics, importation issues. FDA issues. Drug safety issues. Clinical trial issues. Conflict of interest, follow on biologics, steroid abuse, stem cells. PDUFA. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing issues. HR 328, Pharmaceutical Market Access Act of 2005. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006. S 3807, Bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. S 4016 & HR 6257, Bill to amend the Public Health Service Act to provide for the licensing of comparable biological products, and for other purposes HR 2565, Office of National Drug Control Reauthorization Act. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. HR 810, Stem Cell Research Enhancement Act of 2005. S 109, Pharmaceutical Market Access Act of 2005.
GENZYME via PODESTA GROUP, INC.
2006 · year_end · YY
H.R.4241, Deficit Reduction Act of 2005 S.1932, Deficit Reduction Omnibus Reconciliation Act of 2005 Medicare Implementation; Flow Cytometry; Medicaid; 340B Program; HOPPS 2007 Reimbursement HR 6111, Tax Relief and Health Care Act of 2006
Sec. 751 drug safety; issues within the bill: drug safety, Critical Path, and follow-on biologicsSenate version of bill: Title IV - Sec.742 FDA conflict on interest language, issues, within the bill Authorized Generics, Citizen's Petition, FTC, Personalized Medicine, follow-on biologics, Critical Path H.R.5672 - FY2007 Science, State, Justice, and Commerce Appropriations bill or Commerce, State, and Justice Appropriations bill--All sections--"Patents/PTO" H.R.5441 - FY 2007 Homeland Security Appropriations bill -- House version of bill - Section 532 "Customs Drug Importation provision" Senate version of bill - Sec. 540 - Customs Drug Importation provision H.R.5647 - FY 2007 Labor, Health, and Human Services and Education and Related Agencies Appropriations bill House Committee Reported bill - Title II - drug, pricing, drug safety H.R.5384, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007 House version of bill, Title VI - Sec. 742: Conflict of Interest; Sec 749 Drug Importation;
NORVARTIS VACCINES & DIAGNOSTICS INC via PODESTA GROUP, INC.
2006 · year_end · YY
HR 6164, National Institutes of Health Reform Act of 2006
HR 6111, Tax Relief and Health Care Act of 2006
S 6257, Access to Life-Saving Medicine Act -Vaccine tracking provisions HR 5533 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S 3678 - Pandemic and All Hazards Preparedness Act. S 1873 - Biodefense and Pandemic vaccine and Drug Development Act of 2005. Flu Vaccine approval issues; Cell culture; pandemic Flu Vaccine; Clinical Trials.
2006 · year_end · YY
S 3807, Enhancing Drug Safety and Innovation Act of 2006 FDA Drug Safety Oversight Follow-On-Biologics HR 6257, Access to Life-Saving Medicine Act S 4016, Access to Life-Saving Medicine Act
HR 2795, Patent Act of 2005 Intellectual Property and Process Patent Issues S 3818, Patent Reform Act of 2006
Implementation of HR 1 Medicare Prescription Drug and Modernization Act of 2003. Medicaid and Medicare Coverage and Reimbursement. HR 6111, Tax Relief and Health Care Act of 2006.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2006 · year_end · YY
House version of Title VI, Section 742 - Conflict of Interest; Section 749 - Drug Importation Section 751 - Drug safety "Critical Path" drug safety. Agency for Healthcare Quality and Research. S Con Res. 83 - Senate Budget Resolution H Con Res. 376 - House Budget Resolution HR 5672 - FY 2006 Science, State, Justice and Commerce Appropriations bill or Commerce, State and Justice Appropriations bill - patents/PTO HR 5647, Department of Labor, health and Human Services, and Education and related Agencies Appropriations Act, 2007 Bill HR 5384 - FY 2007 Agriculture, Rural Development, Food and Drug Administration Appropriations Bill.
Drug safety clinical trials importation issues; conflict of interest. PDUFA S 3802, To amend the Consolidated Omnibus Budget Reconciliation Act of 1985 to expand the county organized health insuring organizations authorized to enroll Medicaid beneficiaries. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005 S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 328, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005
PFIZER INC via PODESTA GROUP, INC.
2006 · year_end · YT
641 Medicare demo HR 6111, Tax Relief and Health Care Act of 2006
HR 4157 Health Information Technology Promotion Act of 2005. S 1418 Wired for Health Care Quality Act.
S 3880, Animal Enterprise Terrorism Act
SIGMA TAU PHARMACEUTICALS via PODESTA GROUP, INC.
2006 · year_end · YT
ESRD drug coverage. HR 6111, Tax Relief and Health Care Act of 2006 HR 4241, Deficit Reduction Act of 2005. S 1932, Deficit Reduction Omnibus Reconciliation Act of 2005. Medicare Coverage Implementation. National Coverage Determination.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH via PODESTA GROUP, INC.
2006 · year_end · YY
HR 2795, Patent Act of 2005 S 3818, Patent Reform Act of 2006 Patent Reform
HR 6111, Tax Relief and Health Care Act of 2006 340 B Drug Prices 2007 PFS and HOPPS Reimbursement H.R.4241, Deficit Reduction Act of 2005 S.1932, Deficit Reduction Omnibus Reconciliation Act of 2005 Medicare Implementation Issues Medicaid
Corporate accounting/ tax treatment of stock options. HR 6111, Tax Relief and Health Care Act of 2006
RELX INC via PODESTA GROUP, INC.
2006 · year_end · YY
S 500, Information Protection and Security Act HR 3997, Financial Data Protection Act of 2006 - all sections related to data brokers and privacy S 1789, Personal Data Privacy and Security Act of 2005 - all sections related to data brokers and privacy S 1408, Identity Theft Protection Act - all sections related to data brokers and privacy HR 4127, Data Accountability and Trust Act (DATA) - all sections related to data brokers and privacy S 2169, Financial Data Protection Act of 2005 - all sections related to data brokers and privacy Privacy issues
S 2695, Federal Research Public Access Act of 2006. S 2106, American Center for Cures Act of 2005.
NOVO NORDISK INC via PODESTA GROUP, INC.
2006 · year_end · YY
2007 HOPPS reimbursement. Diabetes screening benefits. HR 6111, Tax Relief and Health Care Act of 2006 HR 4241, Deficit Reduction Act of 2005. S 1932, Deficit Reduction Omnibus Reconciliation Act of 2005. Medicare drug coverage implementation issues. 340B
HR 3010, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2006. Diabetes Research Issues. HR 6164, National Institutes of Health Reform Act of 2006.
The Senate version of the bill: Title VI; Section 742 "FDA conflict of interest" language "Authorized Generics" Citizen's Petition" and FTC "Personalized Medicine" Critical Path, follow-on biologics HR 5631 - FY 2007 Department of Defense Appropriations bill - House version of the bill - diabetes/obesity initiatives, blood clotting issues Tracking Funds for the national Institute of Diabetes and Digestive and Kidneys HR 5441 - FY 2007, Homeland Security Appropriations bill - House version - biologics, drug importation exemption HR 5384 - FY 2007 Agriculture, Rural Development, Food and Drug Administration Appropriations bill The House version of the Title VI; Section 742: "Conflict of Interest" Section 749 "Drug Importation" Section 751 "drug safety" "Critical Path" "drug safety"
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA via PODESTA GROUP, INC.
2006 · year_end · YT
Drug importation, drug safety issues, clinical trials Conflict of Interest, PDUFA, Drug pricing S 2766, national Defense Authorization Act for Fiscal Year 2007; drug pricing. HR 2090, Food and Drug Administration Improvement Act of 2005 HR 328, Pharmaceutical Market Access Act of 2005. S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act HR 6257, Access to Life-Saving Medicine Act HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation. S 109, Pharmaceutical Market Access Act of 2005. S 334 Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.
HR 5631, FY 2007 Department of Defense Appropriations bill. HR 5672, FY 2007 Science, State, Justice and Commerce Appropriations bill or Commerce, State and Justice Appropriations bill, Title I: DEA, Title II: patent related issues/PTO. HR 5441, FY 2007 Homeland Security Appropriations bill, The House Passed version: title III, Section 532 Custom Drug Importation provision - The Senate passed version, Custom Drug Importation provision. HR 5385, FY 2007 Military Quality of Life, Military Construction, Department, Department of VA and Related Agencies Appropriations bill - The House passed bill includes, mail order pharmacy. HR 4939 Emergency Supplement Appropriations for FY 2006, Look for drug importation, drug pricing and drug safety provision. S Con Res. 83; H Con Res. 376 HR 5384, FY 3007 Agriculture, Rural Development, Food and Drug Adminstriation Appropriations bill. HR 5647, FY 2007 Labor, Health and Human Services, and Education and related Agencies Appropriations.- The House Committee Reported bill (Title II): drug pricing, drug safety.
ORANGE COUNTY, FLORIDA via PODESTA GROUP, INC.
2006 · year_end · YY
Orange County Bird Flu Summit
Central Florida Veteran's Hospital
HR 5576, Transportation, Treasury, Housing and Urban Development, the Judiciary, the District of Columbia, and Independent Agencies Appropriations Act, 2006/HUD/EDI, DOT. Work to acquire funding (appropriations). HR 5672, SSJ, Commerce, and Related Agencies Appropriation Act, 2006/Byrne Grants Accts. HR 5647, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006/SAMHSA, HRSA accounts.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
GENZYME via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SIGMA TAU PHARMACEUTICALS via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORANGE COUNTY, FLORIDA via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2006 · mid_year · MM
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NORVARTIS VACCINES & DIAGNOSTICS INC via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
RELX INC via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHIRON via PODESTA GROUP, INC.
2006 · mid_year · MT
Filing targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2006 · mid_year · MM
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NORVARTIS VACCINES & DIAGNOSTICS INC via PODESTA GROUP, INC.
2006 · mid_year · RR
GENENTECH via PODESTA GROUP, INC.
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA via PODESTA GROUP, INC.
2005 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2005 · year_end · YY
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2005 · year_end · YY
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2005 · year_end · YY
H.R.2795, Patent Act of 2005 Patent Reform
H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005 S.109, Pharmaceutical Market Access Act of 2005 S.334, Pharmaceutical Market Access and Drug Safety Act of 2005 S.930, Food and Drug Administration Safety Act of 2005 Drug safety and importation issues, Clinical trials Generics, Biologics
H.R.4241, Deficit Reduction Act of 2005 S.1932, Deficit Reduction Omnibus Reconciliation Act of 2005 Medicare drug coverage implementation issues
EMD SERONO INC via PODESTA GROUP, INC.
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHIRON via PODESTA GROUP, INC.
2005 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
GENENTECH via PODESTA GROUP, INC.
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, open access policy/NIH provisions S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, open access policy/NIH provisions
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion
S. 1145, Patent Reform Act of 2007, entire bill H R. 1908, Patent Reform Act of 2007, entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC)
H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion H. Con. Res. 99, Budget Resolution, Medicare/Medicaid provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid provisions H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion
S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill
S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare provisions H. R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions S. 1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FDA/drug importation provisions H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
HR 2795, Patent Act of 2005. Patent Reform
340B Issues, 641 Demo issues. 2007 HOPPS reimbursement issue. HR 6111, An act to amend the Internal Revenue Code of 1986 to extend expiring provisions, and for other purposes. HR 4241, Deficit reduction Act of 2005. S 1932, Deficit Reduction Omnibus Reconciliation Act of 2005. Implementation of HR 1 Medicare Prescription Drug and Modernization Act. Medicaid
HR 5384, FY 2007 Agriculture, Rural Development, Food an Drug Administration Appropriations billThe Senate version of the bill: Title VI, Section 742 "FDA conflict of interest" language Authorized Generics, Citizen's Petition and FTC, Personalized Medicine, Critical Path, follow-on biologics- HR 5441, FY 2007 Homeland Security Appropriations bill. The House Passed version: Title III Section 532 "Customs Drug Importation provision" The Senate Passed version: Sec. 540 Customs Drug Importation provision. HR 5647, FY 2007 Labor, health and Human Services, and Education and related Agencies Appropriations bill, drug pricing, drug safety. HR 4939 Emergency Supplemental Appropriations for FY 2006, Look for drug importation, drug pricing and drug safety provision. HR 5672, FY 2007 Science, State, Justice and Commerce Appropriations bill of Commerce, State and Justice Appropriations bill Patents/PTO. HR 5384, FY 2007 Agriculture, Rural Development, Food and Drug Administration Appropriations bill -- The House version of the Title VI - Section 742: "Conflict of Interest", Section 749 "Drug Importation" Section 751, Critical Path, drug safety, follow-on biologics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.2795, Patent Act of 2005 Process Patents Patent Reform S 3818, Patent Act of 2006
FDA, drug approval, generics biologics, importation, clinical trial, drug and safety, PDUFA, conflict of interest HR 2090, Food and Drug Administration Improvement Act of 2005 HR 6257, Access to Life-Saving Medicine Act S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation S.109/H.R.328, Pharmaceutical Market Access Act of 2005 S.334, Pharmaceutical Market and Drug Safety Act of 2005 S.930, Food and Drug Administration Safety Act of 2005
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 5122, National Defense Authorization Act for Fiscal Year 2007. S 2766, Department of Defense Authorization Act for Fiscal Year 2007. S 1873 - Biodefense and Pandemic vaccine and Drug Development Act of 2006 Cell Culture Technology.
HR 5533, Biodefense and Pandemic Vaccine and Drug Development Act of 52006 S 3678, pandemic and All-Hazards Preparedness Act. S 1873, Biodefense and Pandemic Vaccine and Drug Development Act of 2005 Anti-trust exemption.
S 1873 - Biodefense and Pandemic vaccine and Drug Development Act of 2006. Liability reform for Vaccine, Pandemic Flu, Bitterroots Legislation. HR 5122 - National Defense Authorization Act for Fiscal Year 2007. S 2766 - Department of Defense Authorization Act for Fiscal Year 2007. HR 5533 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S 3678 - Pandemic and All Hazards Preparedness Act.
HR 5631 - FY 2007 Department of Defense Appropriations bill - House version of the bill - pandemic influenza related provisions. S. Con Res. 83 - Budget Resolution. H. Con Res. 376 - Budget Resolution. HR 5441 - FY 2007 Homeland Security Appropriations bill - House Version of bill - Title III - Countermeasure/Pandemic provisions; Section 532 - Customs Drug Importation provision; Senate version of bill - Sec. 540 - Customs Drug Importation provision; domestic preparedness. HR 5385 - FY 2007 Military Quality of Life, Military Construction, Department of VA and Related Agencies Appropriations bill - House version of bill - avian influenza. HR 5647 - FY 2007 Labor, Health and Human Services, and Education and related Agencies appropriations bill House Committee Reported bill - Title II: CDC, pandemic influenza. HR 4939 Emergency Supplemental Appropriations for FY 2006 - Section 2607 and Title IV - pandemic influenza funds, pandemic vaccine liability. HR 5384 - FY 2007 Agriculture, Rural Development, Food and Drug Administration Appropriations bill - House Version of the bill - issues - pandemic preparedness. Senate version of the bill - issues - pandemic preparedness, influenza.
Filing targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 2795, Patent Act of 2005 Patent Reform S 3818, Patent Act of 2006
304B; 2007 HOPPS reimbursement; 641 Demo HR 6111, Tax Relief and Health Care Act of 2006 HR 4241, Deficit reduction Act of 2005. S 1932, Deficit Reduction Omnibus Reconciliation Act of 2005. Medicare Coverage issues. Medicaid
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC)
Bioshield reauthorization. S 1873 - Biodefense and Pandemic Vaccine and Drug Development Act of 2005. S 1437 - Bioterror and Pandemic Preparedness Protection Act. HR 5533 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 6257, Access to Life-Saving Medicine Act. S 4016, Access to Life-Saving Medicine Act. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006 Drug Safety, Clinical Trials, drug importation. HR 700/S 334 - Pharmaceutical Market Access and Drug Safety Act of 2005. S 109/HR 328 - Pharmaceutical Market Access Act of 2005. S 930 - Food and Drug Administration Safety Act of 2005.
The Senate version of the bill: Title VI, Section 742 FDA conflict on interest language, Authorized Generics, Citizen's Petition/FTC, Personalized medicine Critical Path - HR 5631 - FY 2007 Department of Defense Appropriations bill, bioterrorism-related provisions. HR 5441 - FY 2007 Homeland Security Appropriations bill, The House Passed version: Title III HR 5441 - FY 2007 Homeland Security Appropriations bill, The Senate Passed version; biological countermeasures. S Con Res 83; H Con Res. 376 HR 5384 - FY 2007 Agriculture, Rural Development, Food and Drug Administration Appropriations bill - The House version of Title VI, Section 742: Conflict of Interest, Section 749 "Drug Importations", Section 751 drug safety, Critical Path, drug safety -
S 852, Fairness in Asbestos Injury resolution Act of 2005 - entire bill.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S 3807, Enhancing Drug Safety and Innovation Act of 2006 HR 6257, Access to Life-Saving Medicine Act Drug Approval Issues, Drug Safety Issues, FDA Issues Clinical Trials Conflict of Interest, Follow-on Biologics, PDUFA IV Issues relating to generics, biotechnology, and drug reimportation H.R.700/S334 Pharmaceutical Market Access and Drug and Safety Act of 2005/S334 H.R.328/S109 Pharmaceutical Market Access Act of 2005 S930 Food and Drug Administration Safety Act of 2005
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Copyright and patent issues
S 3708, Labor, Health and Human Services, and Education, and Related Agencies Appropriations, 2007 HR 5672, Science, State, Justice, Commerce, and Related Agencies Appropriations Act, 2007. HR 5647, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, 2007. Issues relating to NIH public access
HR 6164, NIH Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HR 3010, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006. Diabetes research Issues.
HR 2795, Patent Act of 2005 Patent Reform S 3818, Patent Reform Act of 2006
Drug safety and importation issues, Clinical trials. Generics Biologics HR 328, Pharmaceuticals Market Access Act of 2005. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. S 109, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
S 2766, National Defense Authorization Act for Fiscal Year 2007. HR 6164, National Institutes of Health Reform Act of 2006. Avian Flu Legislation. HR 5122, National Defense Authorization Act for Fiscal Year 2007. HR 5533, Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S 3678, Pandemic and All Hazards Preparedness Act. S 1873, Biodefense and Pandemic Vaccine and Drug Development Act of 2006.
HR 6111, Tax Relief and Health Care Act of 2006. Non-Interference. Drug pricing HR 4241, Deficit Reduction Act of 2005. S 1932, Deficit Reduction Omnibus Reconciliation Act of 2005. Medicare and Medicaid implementation/reform. 340B Issues
S 3818, Patent Reform Act of 2006
Filing targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
H.R.3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 Diabetes Research Issues
H.R.2744, Agriculture, Rural Developement, Food and Drug Administration, and Related Agencies Appropriations Act, 2006 H.R. 2863, Department of Defense Appropriations Act, 2006 H.R.3010, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 Tracking Funds for the National Institute on Diabetes and Digestive and Kidneys
H.R.3010, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006 Diabetes Research Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE